Holen Sie sich die Stockscreener-App
4.56
1.51%
-0.07
Schlusskurs vom Vortag:
$4.63
Offen:
$4.57
24-Stunden-Volumen:
113.80K
Relative Volume:
1.67
Marktkapitalisierung:
$65.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.87M
KGV:
-2.8636
EPS:
-1.5924
Netto-Cashflow:
$-21.21M
1W Leistung:
-2.77%
1M Leistung:
+49.02%
6M Leistung:
+146.49%
1J Leistung:
+65.82%
1-Tages-Spanne:
$4.39
$4.75
1-Wochen-Bereich:
$4.09
$4.75
52-Wochen-Spanne:
$1.42
$4.815
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Vergleichen Sie CALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
4.56 | 66.72M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World
Stonepine Capital Management LLC Has $136,000 Stock Position in CalciMedica Inc. $CALC - MarketBeat
Why retail investors favor CalciMedica Inc. stockJuly 2025 Closing Moves & Weekly Top Gainers Alerts - Newser
CalciMedica (CALC) Stock Analysis Report | Financials & Insights - Benzinga
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial - Investing.com Australia
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial By Investing.com - Investing.com South Africa
CalciMedica announces presentation of data from Preclinical Study of Auxora - MSN
Is CalciMedica Inc. stock a smart buy before Fed meetingQuarterly Trade Summary & Capital Efficiency Focused Ideas - newser.com
From Calcium Channels To Cash Runway: Why CalciMedica Is A Stock To Watch - RTTNews
Will CalciMedica Inc. stock pay special dividendsJuly 2025 Action & Target Return Focused Picks - newser.com
What MACD and RSI say about CalciMedica Inc.July 2025 Outlook & Consistent Profit Alerts - newser.com
Technical signs of recovery in CalciMedica Inc.2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
Is CalciMedica Inc. still worth holding after the dipTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Is CalciMedica Inc. stock near bottom after declinePortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
What recovery options are there for CalciMedica Inc.2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Is CalciMedica Inc. stock reversal real or fakeGap Down & Weekly Return Optimization Plans - newser.com
Tools to monitor CalciMedica Inc. recovery probability2025 Market Trends & Expert Curated Trade Ideas - newser.com
Best data tools to analyze CalciMedica Inc. stockTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
How to build a custom watchlist for CalciMedica Inc.July 2025 Catalysts & Smart Swing Trading Alerts - newser.com
Analyzing CalciMedica Inc. with risk reward ratio chartsJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Why CalciMedica Inc. stock remains on buy listsJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Should I hold or sell CalciMedica Inc. stock in 2025Market Rally & Scalable Portfolio Growth Methods - newser.com
Can CalciMedica Inc. recover in the next quarterWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com
Will CalciMedica Inc. stock return to pre crisis levelsJuly 2025 Update & Growth Focused Entry Reports - Fundação Cultural do Pará
CalciMedica Pushes Forward Despite Widening Losses And Rising R&D Costs - Finimize
Analyzing drawdowns of CalciMedica Inc. with statistical tools2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):